Thomas B. Causey
New England Biolabs
4 Papers
8 Citations
Thomas B. Causey is an academic researcher from New England Biolabs. The author has contributed to research in topics: Phosphatase & Chemistry. The author has an hindex of 3, co-authored 4 publications.
Chat about Author
Papers
Structure of the trehalose-6-phosphate phosphatase from Brugia malayi reveals key design principles for anthelmintic drugs.
Jeremiah D. Farelli,Brendan D. Galvin,Zhiru Li,Chunliang Liu,Miyuki Aono,Megan Garland,Olivia E. Hallett,Thomas B. Causey,Alana Ali-Reynolds,Daniel J. Saltzberg,Clotilde K. S. Carlow,Debra Dunaway-Mariano,Karen N. Allen +12 more
TL;DR: The conservation of the key residues that enforce the shape of the substrate pocket in T6PP enzymes suggest that development of broad-range anthelmintic and antibacterial therapeutics employing this platform may be possible.
A Novel Regulated Hybrid Promoter That Permits Autoinduction of Heterologous Protein Expression in Kluyveromyces lactis.
Hassan Sakhtah,Juliane Behler,Juliane Behler,Alana Ali-Reynolds,Thomas B. Causey,Saulius Vainauskas,Christopher H. Taron +6 more
TL;DR: The P350 hybrid promoter is a strong derepressible promoter for use in autoinduction of one-step fermentation processes for the production of heterologous proteins in K. lactis and demonstrates that P350 is tightly repressed in the presence of glucose or glycerol and becomes derepressed upon depletion of these compounds by the growing cells.
12
Engineering Escherichia coli BL21(DE3) Derivative Strains To Minimize E. coli Protein Contamination after Purification by Immobilized Metal Affinity Chromatography
TL;DR: Two E. coli BL21(DE3) derivatives are engineered that uniquely complement existing methods for improving the purity of recombinant His-tagged protein and can be efficiently eliminated from an IMAC elution fraction using a chitin column flowthrough step.